10-Q: Hawkins Reports Q3 Sales Growth Amid Acquisition Spree

Hawkins, Inc. reported an 8% increase in Q3 sales to $244.1 million, driven by strong performance in its Water Treatment and Industrial Solutions segments, despite a decline in net income due to higher interest expenses from recent acquisitions.

Summary

• Total sales for the three months ended December 28, 2025, increased by 8% to $244.1 million, up from $226.2 million in the prior year.
• Net income for the three months decreased by 4.7% to $14.3 million, down from $15.0 million in the prior year, primarily due to a significant increase in interest expense.
• Diluted earnings per share (EPS) for the three months were $0.69, a decrease from $0.72 in the same period last year.
• For the nine months ended December 28, 2025, sales grew by 12% to $817.8 million, while net income decreased by 2.8% to $66.1 million.
• The Water Treatment segment saw sales increase by 21% to $120.5 million for the quarter, largely due to approximately $19 million in added sales from acquired businesses.
• The Food & Health Sciences segment experienced a 10% sales decrease to $70.0 million for the quarter, attributed to lower volumes in food, health & nutrition, and agricultural products.
• Industrial Solutions segment sales increased by 10% to $53.6 million for the quarter, driven by increased sales volumes of manufactured, blended, and repackaged products.
• The company completed six acquisitions in the first nine months of fiscal 2026, including WaterSurplus, Inc. for an initial purchase price of $149.9 million, contributing to a total acquisition spending of $167.1 million.
• Long-term debt, net of current portion, significantly increased to $253.4 million as of December 28, 2025, from $138.9 million at March 30, 2025, primarily to fund acquisitions.
• Cash provided by operating activities increased to $106.6 million for the nine months, up from $80.3 million in the prior year, driven by favorable changes in trade receivables and inventories.

Sentiment

Score: 5

Explanation: The filing presents a mixed financial picture. While sales growth is strong, driven by strategic acquisitions, profitability (net income and EPS) has declined due to significantly higher interest expenses. The Water Treatment segment shows robust performance, but the Food & Health Sciences segment is struggling. The aggressive acquisition strategy is expanding market reach but also increasing debt and associated costs.

Positives

• Overall sales increased by 8% for the quarter and 12% for the nine months, demonstrating strong top-line growth.
• The Water Treatment segment showed robust growth, with sales up 21% and operating income up 31% for the quarter, significantly boosted by recent acquisitions and improved pricing.
• The Industrial Solutions segment also performed well, with sales increasing 10% and gross profit up 18% for the quarter due to higher sales volumes of value-added products.
• Cash provided by operating activities saw a substantial increase to $106.6 million for the nine months, indicating improved operational cash generation.
• The company successfully expanded its revolving credit facility to $400.0 million, providing ample liquidity for future operations and strategic initiatives.
• Cash dividends declared per common share increased to $0.19 for the quarter and $0.56 for the nine months, reflecting a commitment to shareholder returns.
• Management confirmed compliance with all covenants of the Credit Agreement as of December 28, 2025, and expects to remain in compliance for the next 12 months.

Negatives

• Net income decreased by 4.7% for the quarter and 2.8% for the nine months, primarily due to a significant rise in interest expense.
• Diluted earnings per share (EPS) declined to $0.69 for the quarter and $3.17 for the nine months, compared to $0.72 and $3.25 respectively in the prior year.
• Interest expense, net, surged to $3.4 million for the quarter (from $1.2 million) and $10.5 million for the nine months (from $3.9 million), reflecting increased debt levels from acquisitions.
• The Food & Health Sciences segment experienced a 10% sales decrease and a 15% gross profit decrease for the quarter, driven by lower volumes and competitive pricing pressures.
• Selling, general and administrative (SG&A) expenses increased by 18% for the nine months, largely due to costs associated with acquired businesses, including intangible amortization and fair value accretion on earnout liabilities.
• The LIFO reserve increased by $0.8 million for the nine months, decreasing gross profit, primarily due to a projected increase in certain commodity volumes and costs at year-end.

Risks

• The company is exposed to market risks related to interest rates, particularly on its variable-rate debt under the Revolving Loan Facility, despite having an interest rate swap for a portion of it.
• The cyclical nature of commodity chemical prices poses a risk, as the company attempts to pass changes in material costs to customers, but there are no assurances this will always be possible.
• Environmental remediation liabilities, specifically the $7.7 million related to PCBs at the Rosemount, MN facility, carry uncertainties, and reserves may prove insufficient, potentially leading to additional future expenses.
• The earnout liabilities for acquisitions like WaterSurplus and Water Solutions are based on achieving certain targets, and changes in projected estimates can lead to fair value adjustments impacting SG&A expenses.
• The company's growth strategy relies on acquisitions, which inherently carry risks related to integration, realization of synergies, and potential for increased debt and earnout obligations.

Future Outlook

The company expects its effective income tax rate for the full fiscal year to be approximately 26% to 27%. Management anticipates that current cash balances, funds available under the credit facility, and cash flows from operations will be sufficient to meet ongoing operational cash requirements for the foreseeable future. The company also plans to continue pursuing acquisitions or strategic relationships to complement or expand existing businesses and customer base.

Management Comments

• We realigned our reporting segments to better reflect how we manage our operations and allocate resources, and our evolution from a bulk commodity distributor into a specialty ingredients company.
• We focus on operating income when evaluating our financial results as opposed to profitability as a percentage of sales, as sales dollars tend to fluctuate as raw material prices rise and fall.
• The year-over-year increase in cash provided by operating activities in the current period was primarily driven by favorable year-over-year changes in trade receivables and inventories.
• We expect our cash balances and funds available under our credit facility, along with cash flows generated from operations, will be sufficient to fund the cash requirements of our ongoing operations for the foreseeable future.
• As part of our growth strategy, we have acquired businesses and may pursue acquisitions or other strategic relationships in the future that we believe will complement or expand our existing businesses or increase our customer base.

Industry Context

Hawkins, Inc. is actively transforming from a bulk commodity distributor to a specialty ingredients company, a trend observed across the chemical industry as companies seek higher-margin, value-added products and solutions. The significant acquisition activity, particularly in the Water Treatment segment, positions the company to capitalize on growing demand for sustainable water treatment solutions. However, the Food & Health Sciences segment's decline due to competitive pricing pressures suggests a challenging environment in certain specialty markets, requiring strategic adjustments to maintain profitability. The increased debt load for acquisitions is a common industry practice for growth, but also exposes the company to interest rate risks.

Comparison to Industry Standards

• The company's shift towards specialty ingredients and solutions, particularly in Water Treatment, aligns with broader industry trends where companies like Ecolab and Veolia Water Technologies are focusing on advanced treatment technologies and services to address increasing water scarcity and regulatory demands.
• The decline in the Food & Health Sciences segment due to competitive pricing pressures suggests that Hawkins may be facing challenges similar to those experienced by larger diversified chemical companies such as BASF or Dow, which often encounter pricing volatility in certain commodity-like specialty chemical markets.
• The substantial increase in goodwill and intangible assets from acquisitions, such as WaterSurplus, is typical for companies pursuing inorganic growth strategies to gain market share and specialized capabilities, comparable to moves seen by companies like Brenntag or Univar Solutions in the distribution space.
• The company's effective interest rate of 4.8% on borrowings, while higher than the previous year, is within a reasonable range given the current rising interest rate environment, similar to financing costs observed for other mid-cap industrial chemical distributors expanding through debt-financed acquisitions.

Legal Proceedings

• No material pending legal proceedings, other than ordinary routine litigation incidental to the business, were reported.

Stakeholder Impact

• Shareholders: Experienced a decrease in diluted EPS but an increase in cash dividends per common share. The share repurchase program remains authorized but no shares were repurchased in the current period.
• Employees: Share-based compensation plans are in place, and new employees from acquisitions received restricted stock awards to incentivize continued service.
• Customers: Benefit from expanded product offerings and market reach, particularly in water treatment solutions, due to recent acquisitions.
• Creditors: The company has significantly increased its debt but remains in compliance with all covenants of its credit agreement, indicating a manageable debt position for now.
• Suppliers: The company's operations involve purchases of large quantities of bulk chemicals, making it sensitive to the timing of purchases and commodity price fluctuations.

Next Steps

• Continue to integrate recently acquired businesses, particularly WaterSurplus, into the Water Treatment segment.
• Monitor and manage the increased debt levels and associated interest expenses.
• Address the challenges in the Food & Health Sciences segment, including competitive pricing pressures and declining volumes.
• Evaluate the impact of new accounting pronouncements (ASU No. 2023-09 and ASU No. 2024-03) on future disclosures.
• Potentially pursue further acquisitions or strategic relationships to complement or expand existing businesses.
• Continue to manage the environmental remediation liability at the Rosemount, MN facility.

Key Dates

Recommendation

The company demonstrates strong top-line growth driven by strategic acquisitions, particularly in the Water Treatment segment, which is a positive long-term indicator. However, this growth comes at a cost, with significantly increased debt leading to a notable decline in net income and EPS due to higher interest expenses. The underperformance of the Food & Health Sciences segment also presents a concern. While the company is expanding its market presence and operational cash flow is healthy, the immediate impact on profitability and the increased leverage warrant a 'hold' recommendation. Investors should monitor the successful integration of acquisitions, the management of debt, and the turnaround efforts in the underperforming segment before considering further investment.

Keywords

Water Treatment, Food & Health Sciences, Industrial Solutions, Acquisitions, Specialty Ingredients, Chemical Distribution, SEC Filing, Earnings, Revenue Growth, Debt, Interest Rates, Environmental Liability, Share Repurchase